Using AI to Design Drugs by Understanding Molecular Shapes
This patent describes a computer system that uses advanced math to describe molecule shapes and then feeds that information into artificial intelligence to predict how well potential drugs will work or if they'll be toxic.
Patent Number
US 20190304568
Status
Active
Filing Date
April 1, 2019
Grant Date
—
Expiration
April 1, 2039
Claims
23
Assignee
Michigan State University
Inventors
Guowei Wei, Zixuan Cang, Duc Nguyen
Citations
101 forward · 5 backward
What it covers
The system identifies potential drug compounds based on desired characteristics or clinical applications (Claim 1). It then uses special mathematical techniques like "persistent homology" and "graph theory" to create "feature data" that describes their complex 3D structures (Abstract, Claim 1). This feature data, which can include "element specific topological fingerprint records" (Claim 3) or "interactive element specific persistent homology barcodes" (Claim 4), is then fed into "trained machine learning models" (Claim 1). These models predict important characteristics, such as "protein binding affinity" (Claim 3) or "protein folding energy change upon mutation" (Claim 4). Finally, the system displays an "ordered list" of the most promising compounds based on these predictions (Claim 1, Claim 2). For example, it could predict which new molecule will bind most effectively to a specific protein target.
What it doesn't cover
- —Does not cover drug design methods that do not use machine learning to predict molecular characteristics.
- —Does not cover predicting molecular characteristics without using feature data derived from persistent homology or graph theory.
- —Does not cover systems that predict drug properties without displaying an ordered list of candidate compounds.
- —Does not cover traditional drug screening methods that rely solely on laboratory experiments without computational prediction.
The clever bit
The novelty lies in combining sophisticated mathematical tools like persistent homology and graph theory to capture the complex, multi-scale geometric and topological features of molecules, and then feeding these unique "fingerprints" into powerful machine learning algorithms to accurately predict molecular characteristics. This allows the AI to "see" and understand molecular shapes in a way that was previously difficult for computers.
Why it matters
Drug discovery is a long, expensive process. This patent aims to speed it up significantly by using computers to predict how potential drugs will behave before they are even synthesized or tested in a lab. By identifying promising compounds earlier, it could reduce costs and accelerate the development of new medicines, making the process more efficient.
Real-world examples
- 1.Computational drug discovery platforms
- 2.AI-driven pharmaceutical research
- 3.Virtual screening for new drug candidates
- 4.Predicting protein-ligand interactions
- 5.Optimizing drug toxicity profiles
Generated by PatentBrief · Not legal advice · patentbrief.org
US 20190304568 · 2026